AroCell AB (publ) signed a Supply and License agreement with Jiangsu Zecen Biotech Co., Ltd. for the distribution of the product TPS CLIA on their automated platforms on the Chinese market. In 2019, AroCell's subsidiary IDL Biotech began a collaboration with ZECEN Biotech regarding automation of the TPS tumor marker on all of ZECEN Biotech's automated systems. The project has proceeded well and therefore a commercial agreement has now been concluded.